Cycle 2 – Module 8 – Lecture 5 – Slimming hormone treatments: thyroid, GH IGF-1, testosterone in men (2h06)

Content is one video of 2h06, a PDF presentation file, and PDF references on:

Four major hormone therapies may considerably prevent overweight and reduce global or local fat accumulation on the body and improve body composition

  • Thyroid
  • GH (growth hormone)
  • IGF-1
  • Testosterone in men
  • Frequency of thyroid, testosterone, and growth hormone-IGF-1 deficits in the population
  • Overweight symptoms and signs of each of these hormone deficiencies
  • Mechanisms by which these hormone deficiencies cause weight gain
  • Observational studies showing associations between low levels of these hormones and obesity
  • Trials that show these hormone treatments cause weight loss and reduce obesity
  • Typical body parts affected by fat and myxedema accumulation due to thyroid, growth hormone, IGF-1, and testosterone deficiencies
  • Thyroid, growth hormone, IGF-1, and testosterone treatments for overweight hormone-deficient patients: dose adjustments, best product choice
  • Attractive and informative pictures coupled with practical tips make this session a must to attend.
  • Among the scientific data provided are the following:
    • A list of references of scientific studies showing associations between low levels of these hormones and obesity
    • A list of references of the trials where these hormone treatments reduced weight and/or improved body composition

 

Abstract:

This instructive video lecture offers new insights and solutions in weight loss management by correcting 4 major hormone deficiencies with hormone supplements.

The major hormone therapies that may considerably prevent or reduce local fat accumulation on the body while simultaneously improving body composition are thyroid, testosterone, growth hormone, and IGF-1. Thyroid treatment burns calories, increases fat breakdown, and takes away myxedema. Growth hormone (GH), insulin-like factor 1 (IGF-1), and testosterone increase muscle mass and decrease fat mass.

Lower levels of thyroid hormones, growth hormone, IGF-1, and testosterone are indisputably associated with higher risks of overweight and obesity. Trials with these hormones showing weight loss and improved body composition are discussed in depth in this presentation. This allows the physician to have a clear view of how much and how quick these hormone therapies can improve overweight patients. These fascinating slides show where exactly (and on which body parts) each of these hormone therapies preferably reduce fat, and the other slides address where there is myxedema accumulation. Additionally, the overweight that each of these hormone deficiencies cause is compared to the typical overweight of insulin excess. For each of these therapies, the best products and doses for overweight patients are presented and explained.

Attractive and informative pictures together with scientific data and practical tips make this video session a must to attend.

 

Educational outcome:
To transmit knowledge on how much thyroid, growth hormone, IGF-1, and testosterone deficiencies may facilitate or even cause overweight, and how hormone supplementations may restore a slim body.

 

Learning outcomes:

The physician learns

  1. How to detect thyroid, growth hormone, IGF-1, and testosterone deficit(s) that cause or increase obesity on symptoms and signs related to overweight
  2. How to differentiate clinically (symptomatically) which of these hormone deficiencies is behind the overweight by recognizing other signs or symptoms of the causative hormone deficiency
  3. How to treat with thyroid, growth hormone, IGF-1, and testosterone, and finetune the doses to the needs and degree of patients’ overweight
  4. More about the scientific studies that support this information, including double-blind placebo-controlled trials

155.00 
Prices exclude VAT.

    • online video course
    • available 24/7 in your private account
    • view or download slides
    • auto enrollment
    • one time fee
    • secure payment
  • Reference: C2_M8_L5.